EASL Clinical Practice Guidelines

Conflicts of interest disclosure

  • Ulrich Beuers has received lecture fees from the Falk Foundation, Gilead, Roche, Schering-Plough and Zambon.
  • Kirsten M. Boberg has received research funding from Meda A/S.
  • Roger W. Chapman has received research support and lecture fees from the Falk Foundation.
  • Olivier Chazouillères has nothing to disclose.
  • Pietro Invernizzi has acted as an advisor and lecturer for Instrumentation Laboratory, Inova Diagnostics, Menarini Diagnostics and Euroimmun.
  • David E.J. Jones has nothing to disclose.
  • Frank Lammert has nothing to disclose.
  • Albert Parès has received research support from Gambro Dialysatoren GmbH, Hechingen, Germany.
  • Michael Trauner has received research support and lecture fees from the Falk Foundation.
  • Antonio Benedetti has nothing to disclose.
  • Peter L.M. Jansen is acting as an advisor to Biolex and Debiopharm and has received funds from Special Products.
  • Hanns-Ulrich Marschall has received research support from the Falk Foundation and MEDA AB.
  • James Neuberger has received speaker support from the Falk Foundation, Roche and Astellas and has been a principal investigator for Roche.
  • Gustav Paumgartner has received speaker support from the Falk Foundation.
  • Raoul Poupon has received lecture fees from the Falk Foundation, Sanofi-Aventis, Schering-Plough, Roche and Axcan.
  • Jesús Prieto has received lecture fees from the Falk Foundation.